ITCC 059

About this trial

Phase 1 trial

Patient Profile

Paediatric CD22 positive acute lymphocytic leukemia (ALL).

Where’s this trial being run?

Crumlin Children’s Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information


Here’s a list of questions you may have for your doctor or local cancer research team.

Summary Data

Name: ITCC 059
Number: 18-16
Full Title:

A Phase 1 study of Inotuzumab Ozogamycin as a single agent and in combination with chemotherapy for paediatric CD22-Positive ALL

Principal Investigator: Dr Owen Smith
Type: Collaborative

Erasmus Medical Centre

Recruitment Started: Global: Not Available
Ireland: Not Available
Global Recruitment Target: Not Available
Ireland Recruitment Target: Not Available